4//SEC Filing
Bertrand William C JR 4
Accession 0001104659-25-085820
CIK 0001621227other
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 6:25 PM ET
Size
6.4 KB
Accession
0001104659-25-085820
Insider Transaction Report
Form 4
Bertrand William C JR
Chief Operating Officer
Transactions
- Sale
Ordinary Shares with a nominal value of GBP0.001 per share
2025-08-28$0.01/sh−207,000$2,091→ 986,352 total
Footnotes (4)
- [F1]The ordinary shares whose sale is reported on this line are represented by American Depositary Shares ("ADS") and are held in the form of ADSs by the Reporting Person. Each ADS represents six ordinary shares of the Issuer.
- [F2]The 207,000 ordinary shares reported in Column 4 are represented by 34,500 ADSs.
- [F3]The price reported in Column 4 of $0.01005 per ordinary share is derived from the sale price of $0.0603 per ADS divided by six. These ADSs were sold in multiple transactions at a price of $0.0603. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission with full information regarding the ADSs sold at this price in this footnote.
- [F4]The 986,352 ordinary shares reported in Column 5 are held in the form of 164,392 ADSs by the Reporting Person and represent solely those ADSs held by the Reporting Person following this transaction. Additionally, the Reporting Person holds RSU-style options and other options covering an aggregate of 16,108,722 ordinary shares of the Issuer.
Documents
Issuer
Adaptimmune Therapeutics PLC
CIK 0001621227
Entity typeother
Related Parties
1- filerCIK 0001291937
Filing Metadata
- Form type
- 4
- Filed
- Aug 28, 8:00 PM ET
- Accepted
- Aug 29, 6:25 PM ET
- Size
- 6.4 KB